I'm looking for

All News

Frontline Niraparib Plus Bevacizumab for Advanced Ovarian Cancer Yields Promising Activity

SGO in the News
Apr 13, 2020
Advertisement

Advertise With Us
Related Content
May 25, 2022Eisai Adds All Indicated Doses to Lenvatinib Dose Exchange Program After Research Presented at SGO 2022 Annual Meeting
Apr 27, 2020Herceptin Boosts OS in HER2-Positive Uterine Cancer
Apr 27, 2020Add-On Metformin No Help in Advanced Endometrial Cancer
Apr 13, 2020Frontline Niraparib Plus Bevacizumab for Advanced Ovarian Cancer Yields Promising Activity